Other Income & Expense
Other Income (Expense)
Biogen Other Income (Expense) increased by 99.7% to -$1.10M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 144.0%, from $2.50M to -$1.10M. Over 4 years (FY 2021 to FY 2025), Other Income (Expense) shows an upward trend with a -27.5% CAGR.
Analysis
StatementIncome Statement
SectionOther Income & Expense
CategoryProfitability
SignalContext dependent
VolatilityModerate
First reportedQ1 2014
Last reportedQ1 2026
How to read this metric
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Detailed definition
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Peer comparison
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
Metric ID:
other_income_expense_netHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $96.40M | -$502.90M | -$182.10M | -$263.30M | -$26.20M | $1.70M | $133.40M | $600.00K | -$2.30M | -$3.40M | -$310.40M | -$1.90M | -$2.00M | -$800.00K | -$338.90M | $2.50M | -$3.30M | $15.80M | -$317.60M | -$1.10M |
| QoQ Change | — | -621.7% | +63.8% | -44.6% | +90.0% | +106.5% | >999% | -99.6% | -483.3% | -47.8% | <-999% | +99.4% | -5.3% | +60.0% | <-999% | +100.7% | -232.0% | +578.8% | <-999% | +99.7% |
| YoY Change | — | — | — | — | -127.2% | +100.3% | +173.3% | +100.2% | +91.2% | -300.0% | -332.7% | -416.7% | +13.0% | +76.5% | -9.2% | +231.6% | -65.0% | >999% | +6.3% | -144.0% |
Range-$502.90M – $133.40M
CAGR-61.0%
Avg YoY Growth+92.0%
Median YoY Growth+9.7%
Other Income (Expense) at Other Companies
Frequently Asked Questions
- What is Biogen's other income (expense)?
- Biogen (BIIB) reported other income (expense) of -$1.10M in Q1 2026.
- How has Biogen's other income (expense) changed year-over-year?
- Biogen's other income (expense) decreased by 144.0% year-over-year, from $2.50M to -$1.10M.
- What is the long-term trend for Biogen's other income (expense)?
- Over 4 years (2021 to 2025), Biogen's other income (expense) has grown at a -27.5% compound annual growth rate (CAGR), from -$1.10B to -$302.60M.
- What does other income (expense) mean?
- The net result of all income and expenses not related to core business operations.